1.Determination of troxerutinum and coumarin in Keyanzhong Tablets by HPCE
Han QIU ; Sujian CHEN ; Feiyun YE ;
Chinese Traditional Patent Medicine 1992;0(11):-
Objective: To determine troxerutinum and coumarin in Keyanzhong Tablets. Methods: A HPCE method is used. Ibuprofen is used as internal standard with the running buffer of 25 mmol?L -1 borax boric acid (pH9.2),containing 30 mmol?L -1 SDS and 10% acetonitrile. The running voltage is 20KV, at the detection wavelength of 214nm.Results: The linear ranges of Troxerutinum and Coumarin are 50 250?g?mL -1 ( r = 0.9991 ) and 25 125?g?mL -1 ( r =0.9993),respectively. The average recoveries are 98.4% and 98.8%, respectively. RSD are 1.6% and 2.0% ( n =5),respectively.Conclusion: The method is simple, accurate and sensible, and can be used for quality control of the preparation.
2.Investigation on the necessity of development of information system integration platform in county hospital
Zhaojun CHEN ; Laizheng CAO ; Chengxing HAN ; Ning LIU ; Guohua QIU
Chinese Journal of Primary Medicine and Pharmacy 2017;24(2):316-317,318
Objective To evaluate the necessity of construction of hospital information system integration platform for county Hospital as the urban and rural medical hub in the context of the development of modern medical information.Methods By referring to the development of the domestic and international integration platform,and comprehensively considered the development status of the county hospital,and analyzed based on the perspective of sustainable development.Results The hospital information integration platform was formed to meet the needs of the county hospital,and it platform was used to open up the internal and external medical information resources,realize the integration of business resources and process optimization..Conclusion The county hospital building information system integration platform is the inevitable trend of the current construction of information technology,and its comple-ted construction can enhance province -city-county tertiary care facility data communication,reduce the coupling within the hospital business systems,and make the county hospital more flexible in the future construction and devel-opment.
3.The hemostatic and protective effect of human fibrin sealant on liver trauma in rats
Shaoqing XIA ; Han CHEN ; Yudong QIU ; Yi XUE
Chinese Journal of Biochemical Pharmaceutics 2001;22(2):76-78
Purpose The aim is to investigate the hemostatic and protective effect of fibrin sealant(FS) on liver trauma in rats.Methods On the surface of cracked wound(type Ⅰ) and resected wound(type Ⅱ),spraying of FS or thrombin or direct suturation, was used receptively. Natural hemostasis was used as control.During postoperation the hemostatic time and the state of wound healing on 1st, 4th, 7th,14th, 50th day were observed.Results Compared with the natural hemostasis,the hemostatical time of the FS group was shorter 86.0%(P<0.01)in liver trauma type Ⅰ and 79.0%(P<0.01)in liver trauma type Ⅱ.Compared with the thrombin group,the hemostatical time of the FS group was shorten 45.0%(P<0.01)in liver trauma type Ⅰ and 84.0%(P<0.05) in liver trauma type Ⅱ.The wound surface of FS group was healed faster than that of other groups.Conclusion FS was an effective hemostatic and healing-promoter on liver trauma of rats.
4.Architecture design of county hospital information system integration platform
Zhaojun CHEN ; Laizheng CAO ; Chengxing HAN ; Ning LIU ; Guohua QIU
Chinese Journal of Primary Medicine and Pharmacy 2016;23(14):2238-2240
Based on the current county hospital information construction in the problem of integration,pro-posed a scheme based on a unified architecture application integration platform.The original business system interface standardization of the construction of hospital information systems analysis and integration platform architecture and integration framework,the framework can be achieved through integrated hospital between heterogeneous systems.A unified standardized interfaces can achieve a good cross -system data integration.The construction of county hospitals information system integration platform,data sharing and interaction is conducive to solve the problem of data islands facing the county hospital,hospital to enhance business development capabilities and scale.
5.Changes of mitochondria in human placenta in intrauterine growth restriction
Nan GU ; Xiaohui CHEN ; Xirong GUO ; Yufang QIU ; Shuping HAN
Journal of Clinical Pediatrics 2013;(12):1169-1172
Objective To explore the mechanism of intrauterine growth restriction (IUGR) via observing the change of mitochondria in IUGR placenta. Methods Placenta samples were collected from 30 singleton pregnancies at the time of elec-tive caesarean section. Fifteen of them were appropriate for gestational age and 15 were IUGR. Mitochondrial morphology was observed by transmission electron microscopy, DNA copies were analyzed by real-time quantitative PCR and membrane potential was assayed by lfow cytometry. Results Signiifcant morphological changes of placental mitochondria were observed under transmission electron microscopy in IUGR, mitochondrial DNA copies in IUGR placenta were signiifcantly increased (P<0.01) and membrane potential decreased dramatically (P<0.01). Conclusions It is suggest that impaired mitochondrial function in IUGR may involve in IUGR pathogenesis.
6.Special considerations for patients aged 80 years or over receiving pacemaker implantation
Zhanying HAN ; Xuwei ZHENG ; Chunguang QIU ; Xiaojie CHEN ; Wenjie LU
Chinese Journal of Geriatrics 2014;33(7):748-750
Objective To investigate indications,pacing modes,pacing parameters and postoperative complications of pacemaker implantation for patients aged 80 years or over.Methods Patients were recruited on a continuous basis and were assigned into two groups,with 112 patients in the very elderly (80-90 years old) group and 484 patients in the elderly (60-79 years old) group,which served as the control.Follow-up observations with the two groups were conducted concerning indications,mode selection,pacing parameters and postoperative complications.Results Compared with the control group,the very elderly group showed:1) a higher rate of coronary heart disease (58cases vs.163 cases or 51.8% vs.33.7% ; x2 =12.78,P<0.01) ; 2) more single-chamber pacemaker implantations (63 cases vs.217 cases or 56.3% vs.44.8%; x2=4.76,P<0.05) and fewer dual-or multi-chamber pacemaker implantations (49 cases vs.267 cases or 43.8% vs.55.2% ; x2 =4.76,P<0.05) ; 3) a higher rate of double bundles branch block (19 cases vs.31 cases or 17.0% vs.6.4% ; x2=13.20,P<0.01); 4) a higher rate of postoperative acute cerebral infarction (x2 =8.34,P<0.01) ; and 5) increased ventricular [(0.78±0.24)V vs.(0.55±0.16)V,P<0.05]and atrial [(1.07±0.22)V vs.(0.84±0.28)V,P<0.05]pacing thresholds.Conclusions Special considerations should be made when pacemaker implantation is planned for patients aged 80 or over.Pacemaker selection decisions ought to be based on a comprehensive evaluation of relevant clinical situations so that clinical benefits can be maximized.
7.Study on influential factors associated with the long-term effect of allergic rhinitis specific immunotherapy.
Xianqing LI ; Qianhui QIU ; Hong HAN ; Shaohua CHEN
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2015;29(3):215-218
OBJECTIVE:
To investigate the influential factors associated with the long-term effect of allergic rhinitis (AR) specific immunotherapy (SIT).
METHOD:
Retrospective analyzed the following visual analog scale(VAS) before and after the specific immunotherapy of 219 patients with allergic rhinitis. Logistic regression and pair t-test were used to explore the key factors influencing the prognosis.
RESULT:
(1) The gender and the VAS before specific immunotherapy (P < 0.05) were associated with the long-term effect of allergic rhinitis specific immunotherapy, while family history, the age of specific immunotherapy, number of allergens and stitches and with other allergic diseases (P > 0.05) were not associated with the long-term effect of specific immunotherapy; (2) Compared VAS of different endpoints with VAS before the treatment,there were significant differences. The primary endpoints were the time following no more than half a year (total effective rate: 50.0%), half a year to 1 year (total effective rate: 51.7%), 1 to 2 year (total effective rate: 47.1%), 2 to 3 year (total effective rate: 54.5%) and over 3 year (total effective rate: 40.7%).
CONCLUSION
Apart from the gender and the VAS before specific immunotherapy,genetic and other factors can not significant influence the long-term effect of specific immunotherapy. The effect of specific im- munotherapy seems to last for 3 years at least. Increasing stitches can not improve long-term effect of SIT,but it can consolidate the effect. The long-term effect of specific immunotherapy tends to drop off with fluctuations over time and the higher of VAS before SIT,the better effect of long-term SIT. Further more, the long-term effect of SIT of male is worse than female. In consequences, we speculate epigenetics related to the interaction between environmental factors and genetic factors plays an important role in the long-term effect of allergic rhinitis specific immunotherapy.
Allergens
;
Female
;
Humans
;
Hypersensitivity
;
Immunotherapy
;
Male
;
Retrospective Studies
;
Rhinitis, Allergic
;
therapy
;
Sex Factors
;
Time Factors
8.Promotion of Development of Community-based Rehabilitation in China Implementing ICF and CBR Guideline
Zhuoying QIU ; Jibin HAN ; Qinyi LI ; Di CHEN
Chinese Journal of Rehabilitation Theory and Practice 2014;(9):801-804
This paper discussed the framework of global policies of disability and approaches, explored the implementation of ICF and CBR Guideline, and emphasized the importance of capacity building using ICF and CBR Guideline.
9.Safety of rush allergen-specific immunotherapy in allergic rhinitis patients.
Qianhui QIU ; Chuan LUC ; Jianjun CHEN ; Hong HAN ; Weijia KONG ; Shaohua CHEN
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2014;28(11):776-784
OBJECTIVE:
The safety of rush immunotherapy (RIT) in Chinese allergic rhinitis (AR)patients is unknown. The purpose of this prospective was to assess the safety differences between RIT and conventional immunotherapy in Chinese AR patients, and then discuss the clinical application feasibility of RIT.
METHOD:
A one-year study period was set for this study. The enrolled patients were divided into 2 groups according to their preference of therapy: RIT or conventional immunotherapy using standardized house dust mite allergen vaccine. For safety evaluation, the local and systemic adverse reactions were recorded throughout the both groups initial phase. Week 0 (W0), Week 2 (W2), Week 5 (W5), Week 17 (W17) were set as observation time points for leukotriene (LT-B4) and so on. The Generalized Mixed Linear Model with SPSS13. O and the chi-square test with SAS 9. 1.3 were used for Statistics.
RESULT:
Fifty-two cases were enrolled into the RIT group, of which 49 patients have completed the established treatment study, and 3 cases were lost to follow-up. In the conventional immunotherapy group, 35 cases were enrolled, of which 32 have completed established treatment study, and 3 cases were lost to follow-up. The local and systemic adverse events of AR RIT appeared to be similar to those of conventional therapy and LT-B4 was descended steadily in the two groups.
CONCLUSION
Processed in advance Chinesear with drugs, RIT is similar to the safety of conventional immunotherapy.
Humans
;
Immunotherapy
;
methods
;
Linear Models
;
Prospective Studies
;
Rhinitis, Allergic
;
therapy
10.Establishment of significant neonatal hyperbilirubinemia model for clinical risk assessment
Xiaoyue DONG ; Yulin CHEN ; Shuping HAN ; Zhangbin YU ; Yufang QIU ; Jia CHENG ; Qing SUN
Chinese Journal of Perinatal Medicine 2011;14(8):453-458
Objective To evaluate the predictive accuracy of several risk-assessment strategies to predict the risk of significant neonatal hyperbilirubinemia, and to establish the best prediction model.Methods The transcutancous bilirubin (TcB) levels of 4907 term and near-team infants were measured.Trace blood bilirubin levels of the infants whose TcB levels ≥250 μmol/L were detected. Clinical data of newborns and their mothers were collected and were analyzed with Logistic regression model to investigate its correlation with signifrcant hyperbilirubinemia. Clinical high risk factors of significant neonatal hyperbilirubinemia were determined. Accuracy of three prediction methods for significant hyperbilirubinemia was compared by receiver operating characteristic (ROC) curve. The three methods included: whether predischarge bilirubin level (within 72 hours after birth) expressed in risk zone on an hour-specific bilirubin nomogram; clinical risk factors other than predischarge bilirubin level; and combination of the predischarge bilirubin risk zone and other clinical risk factors. Results Two hundred and eighty-six newborns (5.8%) were found with significant hyperbilirubinemia. The risk factors of significant neonatal hyperbilirubinemia were divided into three groups according to OR: (1) Major risk factors:predischarge (within 72 hours after birth) bilirubin level in the high risk-zone (OR=96. 39, 95% CI:53.32-174.27, P = 0. 000), large cephalohematoma (OR = 36.45, 95% CI: 10. 02-132.56,P=0. 0076), gestational age 35-36+6 weeks (OR= 30. 72, 95% CI 14.47-65.23, P=0. 0001) and exclusive breast feeding and weight loss was >9% of birth-weight (OR=22.44, 95% CI: 4.42-114. 03, P=0. 0016). (2) Minor risk factors: gestational age 37-37+6 weeks (OR=3.26, 95% CI:1.92-5. 55, P=0. 0232), predischarge bilirubin level in P76-P95(OR=13. 64, 95% CI: 8. 10-22.97,P=0. 0001) and bruising (OR = 2.32, 95% CI: 1.14-4.71, P = 0. 0497). (3)Protective factors (those factors associated with decreased risk of hyperbilirubinemia): predischarge bilirubin level in low-risk zone (≤P40) (OR=0. 00), gestational age ≥40 weeks (OR=0.21, 95% CI: 0.09-0.44,P=0. 0402) and mixed breeding (OR=0. 75, 95% CI: 0. 58-0.95, P=0.0059). The area under the ROC curve of predischarge bilirubin level was 0. 8687 and 0. 7375 for clinical risk factors other than predischarge bilirubin level. The area under the ROC curve of a combination of the predischarge bilirubin risk zone and additional clinical risk factors was 0. 9367. Conclusions The risk of significant neonatal hyperbilirubinemia could be simply and accurately predicted by infant's predischarge bilirubin level and the combination of predischarge bilirubin level, and clinical risk factors might improve the accuracy of prediction significantly.